IAM-K2
/ Iambic Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 11, 2026
IAM-K2, a Novel, Brain-penetrant KIF18A Inhibitor for Targeting Chromosomal Instability in Cancer
(EORTC-NCI-AACR 2026)
- "Abstract will be available as of 4 November (with consent of the author)"
Oncology • KIF18A
1 to 1
Of
1
Go to page
1